BRAF mutation analysis by ARMS‐PCR refines thyroid nodule management

Fine‐needle aspiration (FNA) of thyroid nodules leads to nearly 25% indeterminate nodules, while BRAFV600E mutation helps to predicting papillary thyroid carcinoma (PTC). However, the clinical validity and utility of the BRAFV600E mutation detected using preoperative FNA samples in a large cohort were rarely reported.

• Publication year

  2019

• Venue

  Clinical Endocrinology

• Publication date

  2019-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/cen.14079PMID 31441082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules

  2018cited by this paper
• Clinicopathological characteristics and prognosis of thyroid cancer in northwest China: A population‐based retrospective study of 2490 patients

  2018cited by this paper
• American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2017cited by this paper
• Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma–prevalent area

  2017cited by this paper
• The 2017 Bethesda System for Reporting Thyroid Cytopathology.

  2017cited by this paper
• Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications

  2017cited by this paper
• European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS

  2017cited by this paper
• The 2017 Bethesda System for Reporting Thyroid Cytopathology

  2017cited by this paper
• Can thyroid surgery be decided based on ultrasonographic findings, irrespective of cytopathological findings? Five-year retrospective study in a district general hospital.

  2017cited by this paper
• European Thyroid Association Guidelines regarding Thyroid Nodule Molecular Fine-Needle Aspiration Cytology Diagnostics

  2017cited by this paper
• Cancer statistics in China, 2015

  2016cited by this paper
• Molecular cytopathology for thyroid nodules: A review of methodology and test performance

  2016cited by this paper
• Correlation Between Histological Diagnosis and Mutational Panel Testing of Thyroid Nodules: A Two-Year Institutional Experience

  2016cited by this paper
• Clinicopathological features and prognosis of familial papillary thyroid carcinoma – a large‐scale, matched, case–control study

  2016cited by this paper
• Noninvasive Follicular Variant of Papillary Thyroid Carcinoma and the Afirma Gene-Expression Classifier

  2016cited by this paper
• A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma

  2016cited by this paper
• Association between screening and the thyroid cancer “epidemic” in South Korea: evidence from a nationwide study

  2016cited by this paper
• BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients

  2016cited by this paper
• Real-Time PCR Cycle Threshold Values for the BRAFV600E Mutation in Papillary Thyroid Microcarcinoma May Be Associated With Central Lymph Node Metastasis

  2015cited by this paper
• Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.

  2015cited by this paper
• Association between BRAF V600E mutation and regional lymph node metastasis in papillary thyroid carcinoma.

  2015cited by this paper
• Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine‐needle aspiration specimens of papillary thyroid carcinoma

  2015cited by this paper
• A three‐gene panel that distinguishes benign from malignant thyroid nodules

  2015cited by this paper
• Value of TIRADS, BSRTC and FNA-BRAFV600E mutation analysis in differentiating high-risk thyroid nodules

  2015cited by this paper
• Impact of Molecular Testing in the Diagnosis of Thyroid Fine Needle Aspiration Cytology: Data from Mainland China

  2014cited by this paper
• Inhibition of type 1 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions.

  2014cited by this paper
• The increase in thyroid cancer incidence during the last four decades is accompanied by a high frequency of BRAF mutations and a sharp increase in RAS mutations.

  2014cited by this paper
• TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.

  2014cited by this paper
• Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay

  2014cited by this paper
• Prophylactic central neck dissection for papillary thyroid cancer

  2013cited by this paper
• Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.

  2013cited by this paper
• Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.

  2013cited by this paper
• Papillary Microcarcinoma of the Thyroid: Clinical Characteristics and BRAFV600E Mutational Status of 977 Cases

  2013cited by this paper
• Complications of Central Neck Dissection in Patients with Papillary Thyroid Carcinoma: Results of a Study on 1087 Patients and Review of the Literature

  2012cited by this paper
• BRAFV600E mutation and papillary thyroid cancer: chicken or egg?

  2012cited by this paper
• Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.

  2012cited by this paper
• Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.

  2011cited by this paper
• A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.

  2011cited by this paper
• Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.

  2011cited by this paper
• Impact of proto-oncogene mutation detection in cytological specimens from thyroid nodules improves the diagnostic accuracy of cytology.

  2010cited by this paper
• Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

  2009cited by this paper
• Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.

  2009cited by this paper
• An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients

  2009cited by this paper
• The Bethesda Thyroid Fine-Needle Aspiration Classification System: Year 1 at an Academic Institution

  2009cited by this paper
• Cytopathology

  2007cited by this paper
• Fine‐needle aspiration of thyroid nodules: A study of 4703 patients with histologic and clinical correlations

  2007cited by this paper
• Central Lymph Node Dissection in Differentiated Thyroid Cancer

  2007cited by this paper
• Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

  2006cited by this paper
• BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas

  2006cited by this paper
• High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes.

  2005cited by this paper
• BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

  2005cited by this paper
• No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan

  2005cited by this paper
• Galectin-3 and Oncofetal-Fibronectin Expression in Thyroid Neoplasia as Assessed by Reverse Transcription-Polymerase Chain Reaction and Immunochemistry in Cytologic and Pathologic Specimens

  2003cited by this paper

• Can mutation abundance assess the biological behavior of BRAFV600E-positive papillary thyroid carcinoma?

  2025cites this paper
• Combining radiomics and molecular biomarkers: a novel economic tool to improve diagnostic ability in papillary thyroid cancer

  2024cites this paper
• Clinical features combined with ultrasound characteristics to predict TERT promoter mutations in papillary thyroid carcinoma: a single-center study over the past 5 years

  2024cites this paper
• Auxological, Clinical, and MRI Abnormalities in Pediatric Patients With Isolated Growth Hormone Deficiency

  2024cites this paper
• [Clinical significance of multigene assay in papillary thyroid carcinoma].

  2023cites this paper
• MRI-Based Texture Analysis for Preoperative Prediction of BRAF V600E Mutation in Papillary Thyroid Carcinoma

  2023cites this paper
• Significance of FNAC, BRAF mutation, and intraoperative frozen section in surgical decision‐making of thyroid nodules

  2023cites this paper
• A risk stratification system developed to predict contralateral incidental malignant foci in early papillary thyroid carcinoma preoperatively.

  2023cites this paper
• Diagnostic Value and Challenges of BRAF V600E Molecular Testing and Thyroid Fine-Needle Aspiration Cytology: A Retrospective Study from a Tertiary Institution in Southern Hunan Province, China

  2023cites this paper
• Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma

  2023cites this paper
• Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern

  2022cites this paper
• Ultrasonic Artificial Intelligence Shows Statistically Equivalent Performance for Thyroid Nodule Diagnosis to Fine Needle Aspiration Cytopathology and BRAFV600E Mutation Analysis Combined

  2022cites this paper
• Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules

  2021cites this paper
• [Research progress on the relationship between the Raf murine sarcoma viral oncogene homolog B gene mutation and lymph node metastasis of papillary thyroid carcinoma].

  2021cites this paper
• Highly Sensitive Detection of Low-Abundance BRAF V600E Mutation in Fine-Needle Aspiration Samples by Zip Recombinase Polymerase Amplification.

  2021cites this paper
• Genetic Identification of Edible Bird’s Nest in Thailand Based on ARMS-PCR

  2021cites this paper
• ARMS-qPCR Improves Detection Sensitivity of Earlier Diagnosis of Papillary Thyroid Cancers with Worse Prognosis Determined by BRAF V600E and TERT Promoter Co-existing Mutations.

  2021cites this paper
• A Preoperative Nomogram for the Prediction of High-Volume Central Lymph Node Metastasis in Papillary Thyroid Carcinoma

  2021cites this paper
• PET/CT in thyroid cancer - the importance of BRAF mutations.

  2020cites this paper
• The Authors' Reply: Comment on: BRAF mutation analysis by ARMS‐PCR refines thyroid nodule management

  2020cites this paper
• The ratio of BRAFV600E alleles can be used to assess the biological behavior of papillary thyroid carcinoma

  2020cites this paper
• Comment on: BRAF mutation analysis by ARMS‐PCR refines thyroid nodule management

  2020cites this paper
• Corrigendum

  2020cites this paper
• The ratio of BRAFV 600 E alleles can be used to assess the biological 1 behavior of papillary thyroid carcinoma

  2020cites this paper
• Prevalence of BRAFV600E mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review.

  2020cites this paper
• Total thyroidectomy versus lobectomy: surgical approach to T1-T2 papillary thyroid cancer

  2020cites this paper